Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
LifeFlower Breviscapine Brain Formula is a plant-based dietary supplement developed by Farlong Pharmaceutical (also known as Farlong Nutraceutical) to support cognitive function and brain health. The formula's primary active component is breviscapine, a purified extract derived from the medicinal herb *Erigeron breviscapus*, standardized to contain at least 90% scutellarin. Scutellarin is a flavonoid small molecule that promotes healthy cerebral blood circulation and provides neuroprotective support. The product is marketed for the management of mild memory loss associated with aging, as well as for improving concentration and mental clarity. It has received self-affirmed Generally Recognized As Safe (GRAS) status for use in dietary supplements.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on LifeFlower Breviscapine Brain Formula.